FBXW7 and chronic myelogenous leukemia, BCR-ABL1 positive: Loss of FBXW7 results in c-Myc accumulation and p53-dependent apoptosis, preventing initiation of Bcr-Abl-induced chronic myelogenous leukemia (CML) and B-cell acute lymphoblastic leukemia (B-ALL) [17].